These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 34813168)
61. [Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2]. Reina J Rev Esp Quimioter; 2021 Oct; 34(5):402-407. PubMed ID: 33902254 [TBL] [Abstract][Full Text] [Related]
62. Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations. El Hassab MA; Hemeda LR; Elsayed ZM; Al-Rashood ST; Abdel-Hamid Amin MK; Abdel-Aziz HA; Eldehna WM Chem Biodivers; 2022 Feb; 19(2):e202100719. PubMed ID: 34813168 [TBL] [Abstract][Full Text] [Related]
63. Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations. Vishvakarma VK; Singh MB; Jain P; Kumari K; Singh P Amino Acids; 2022 Feb; 54(2):205-213. PubMed ID: 34807314 [TBL] [Abstract][Full Text] [Related]
64. Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis. Sachse M; Tenorio R; Fernández de Castro I; Muñoz-Basagoiti J; Perez-Zsolt D; Raïch-Regué D; Rodon J; Losada A; Avilés P; Cuevas C; Paredes R; Segalés J; Clotet B; Vergara-Alert J; Izquierdo-Useros N; Risco C Antiviral Res; 2022 Apr; 200():105270. PubMed ID: 35231500 [TBL] [Abstract][Full Text] [Related]
65. Plitidepsin: a Repurposed Drug for the Treatment of COVID-19. Martinez MA Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558296 [TBL] [Abstract][Full Text] [Related]